ELTP · Elite Pharmaceuticals Inc /Nv/
$0.29
-0.01 (-2.00%)
At close · Aug 24
Market Cap
$323.14M
Shares
1.08B
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Carter J. Ward | chief financial officer, secretary, and treasurer | Appointed | 2023-09-07 |
| Mark Pellegrino | Chief Financial Officer | Appointed | 2023-05-03 |
| Robert Chen | Chief Financial Officer, Treasurer and Secretary | Resigned | 2023-02-28 |
| Kirko Kirkov | Chief Commercial Officer | Appointed | 2022-09-07 |
| Robert Chen | Chief Financial Officer | Appointed | 2022-05-11 |
| Marc Bregman | Principal Accounting Officer | Resigned | 2022-04-18 |
| Marc Bregman | Treasurer | Resigned | 2022-04-18 |
| Marc Bregman | Chief Financial Officer | Resigned | 2022-04-18 |
| Marc Bregman | Chief Financial Officer | Appointed | 2021-04-29 |
| Carter J. Ward | Chief Financial Officer, Treasurer and Secretary | Resigned | 2021-04-12 |